reports
Sean Conroy
- Sean Conroy
Ellex Medical Lasers - Capitalizing on age-related eye diseases
Ellex’s products target diseases associated with growing ageing populations such as glaucoma and age-related macular degeneration (AMD). FY19 revenue was up 3% to A$81.6m, as robust growth in iTrack, SLT lasers and 2RT was offset by declines in laser devices for other indications and in diagnostic equipment. iTrack, SLT lasers and 2RT appear well-positioned to continue their growth trajectory in FY20 and there may be some recovery in Ellex’s remaining product lines.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.